BB Biotech AG
Research BB Biotech AG (BBZA) on Bullrun: market cap EUR 2.82B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBBZA
- ExchangeXETRA
- CountrySwitzerland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 2.82B
- Financial periodQ1 2026
- Revenue-EUR 17.04M
- Net income-EUR 21.38M
- Free cash flowEUR 373.71M
Valuation Snapshot
latest market cap is EUR 2.82B.
About BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Frequently asked questions
What is BB Biotech AG's market cap?
BB Biotech AG's market capitalization is EUR 2.82B.
What does BB Biotech AG do?
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology.